Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new version of the clinical trial record was submitted on November 4, 2026, and posted the following day, with an update to the study status.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedAn NIH notice points visitors to transition updates and FAQs, explaining that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.4%

- Check29 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check36 days agoChange DetectedA new study-record version was added, reflecting updates to the study status and contact/location information. The page’s displayed revision also advanced to v3.7.1.SummaryDifference0.3%

- Check57 days agoChange DetectedThe footer now displays Revision: v3.7.0, and the contact information link text has been updated from 'Find Contact Information' to 'Find contact information' to reflect a cosmetic UI/typography update on the page.SummaryDifference0.1%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.